Assessment of Safety Signals for Aztreonam in Different Age Groups: National and International Drug Safety Monitoring

• Egile Nagusiak: E. A. Sokova (Egilea), V. V. Arkhipov (Egilea), A. S. Kazakov (Egilea), B. K. Romanov (Egilea), R. N. Alyautdin (Egilea), M. V. Zhuravleva (Egilea)
• Formatua: Liburua
• Argitaratua: Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products», 2022-07-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Aztreonam is the only approved monocyclic β-lactam antibiotic for human use that is active against Gram-negative aerobes, primarily Pseudomonas аeruginosa. Aztreonam has been used for more than 35 years, and aztreonam lysine has been on the market for 15 years. Although the medicinal products show c...